期刊文献+

快速眼球运动睡眠期行为障碍 被引量:3

下载PDF
导出
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2008年第9期706-708,共3页 Chinese Mental Health Journal
基金 北京大学医学部“985工程”二期建设项目“精神病学与精神卫生学”资助(985-2-027-39)
  • 相关文献

参考文献15

  • 1American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed. : Diagnostic and coding manual [ M ] . Westchester, Illinois : American Academy of Sleep Medicine, 2005 : 148 - 153.
  • 2Schenck CH, Mahowald MW. REM Sleep Behavior Disorder: Clinical, Developmental, and Neuroscience Perspectives 16 Years After its Formal Identification in Sleep [J]. Sleep, 2002, 25 (2) : 120 -138.
  • 3李旭东,刘兴洲,王国相.快速眼动期睡眠行为障碍的临床与神经生理研究[J].中华医学杂志,2002,82(13):891-893. 被引量:11
  • 4Iranzo A, Schenck CH, Fonte J. REM sleep behavior disorder and other sleep disturbances in Disney animated films [J] . Sleep Med. 2007, 8 (5): 531-536.
  • 5Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eyemovement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study [ J ] . Lancet Neurol, 2006, 5:572 -577.
  • 6Gagnon JF, Postuma RB, Mazza S, et al. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases [ J ] . Lancet Neurol, 2006, 5 : 424 - 432.
  • 7Gagnon JF, Petit D, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease [J] . Sleep, 2006, 29 (10) : 1321- 1325.
  • 8Terzaghi M, Sinforiani E, Zucchella C, et al. Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease [ J ] . Sleep Med, 2008, 9 (4): 343-351.
  • 9Vendette M, Gagnon JF, De? cary A, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia [J] . Neurology 2007,69 (19) : 1843 - 1849.
  • 107Kumru H, Santamaria J, Tolosa E, et al. Relation between subtype of Parkinson's disease and REM sleep behavior disorder [J] . Sleep Med. 2007, 8 (7 -8) : 779-783.

二级参考文献8

  • 1Boeve BF,Silber MH,Ferman TJ,et al.REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease[].Neurology.1998
  • 2McKeith IG,Perry EK,Perry RH.Report of the second dementia with Lewy body international workshop[].Neurology.1999
  • 3Schenck CH,Bundlie S,Mahowald D.Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder[].Neurology.1996
  • 4Schenck CH,Bundlie SR,Ettinger MG,et al.Chronic behavioral disorders of human REM sleep: a new category of parasomnia[].Sleep.1986
  • 5Lapierre O,Montaplasir J.Polysomnographic features of REM sleep behavior disorder: development of a scoring method[].Neurology.1992
  • 6Schenck CH,Garcia-Rill E,Segall M,et al.HLA class Ⅱ genes associated with REM sleep behavior disorder[].Annals of Neurology.1996
  • 7Olson EJ,Boeve BF,Silber MH.Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases[].Brain.2000
  • 8Plazzi G,Corsini R,Provini F,et al.REM behavior disorders in multiple system atrophy[].Neurology.1997

共引文献10

同被引文献16

  • 1吕望强,胡若笑,朱建唯,陈冲.抑郁障碍的睡眠脑电图研究[J].上海精神医学,2006,18(6):344-345. 被引量:2
  • 2U.S. National Library of Medicine National Center for Biotechnology Information. MEDLINE [DB/OL]. (2010-12-10) [2010-12-11] http://www.ncbi.nlm.nih.gov/pubmed.
  • 3中国医学科学院信息研究所.中国生物医学文献数据库[DB/OL].(2011-1-26)[2011-1-26]http://sinomed.imicams.ac.cn/zh/search.jsp.
  • 4Ancoli-Israel S, Krystal AD, McCall WV, et al. A 12-week, randomized, double-blind, placebo controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia[J]. Sleep, 2010, 33(2): 225-234.
  • 5Richardson GS, Zammit G, Wang-Weigand S, et al. Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study [J]. J Clin Psychiatry, 2009, 70(4): 467-476.
  • 6Mayer G. Wang-Weigand S, Roth-Schechter B, et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia[J]. Sleep, 2009, 32(3): 351-360.
  • 7Wade AG, Ford I, Crawford G, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety [J] BMC Med, 2010, 8(1): 51-68.
  • 8Krystal AD, Durrence HH, Scharf M, et al. Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia [J]. Sleep, 2010, 33(11), 1553- 1561.
  • 9Reynolds III CF, Buysse DJ, Miller MD, et al. Paroxetine treatment of primary insomnia in older adults[J]. Am J Geriatr Psychiatry, 2006, 14(9): 803-807.
  • 10Roth T, Seiden D, Wang-Weigand S, et al. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia [J]. Curr Med Res Opin, 2007, 23(5): 1005-1014.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部